Welcome Guest | Register / Login

Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies

Table of Contents

1. Executive Summary

2. Global Total Market Value of the Top 20 Vaccine Companies (2015 – 2019)

3. Market Share Analysis of the Top 20 Vaccine Companies (%)

4. Key Market Drivers and Inhibitors in the Vaccine Market
4.1 Key Market Drivers
4.2 Key Market Inhibitors

5. Major Deals and Agreement Happenings in the Vaccine Market
5.1 Merger & Acquisitions
5.2 Collaboration Deals
5.3 Licensing Agreement
5.4 Exclusive Agreement
5.5 Distribution Agreement
5.6 Partnership Deals

6. Top 20 Vaccine Companies in the Vaccine Market
6.1 Sanofi Pasteur
6.1.1 Business Overview
6.1.2 Vaccines Portfolio
6.1.3 Vaccines Market Value Analysis
6.1.4 Promising Vaccines in the Clinical Development
6.1.5 Recent Development
6.2 GlaxoSmithKline (GSK) 
6.2.1 Business Overview
6.2.2 Vaccines Portfolio
6.2.3 Vaccines Market Value Analysis
6.2.4 Promising Vaccines in the Clinical Development
6.2.5 Recent Development
6.3 Merck & Co., Inc. 
6.3.1 Business Overview
6.3.2 Vaccines Portfolio
6.3.3 Vaccines Market Value Analysis
6.3.4 Promising Vaccines in the Clinical Development
6.3.5 Recent Development
6.4 Pfizer
6.4.1 Business Overview
6.4.2 Vaccines Portfolio
6.4.3 Vaccines Market Value Analysis
6.4.4 Promising Vaccines in the Clinical Development
6.4.5 Recent Development
6.5 AstraZeneca
6.5.1 Business Overview
6.5.2 Vaccines Portfolio
6.5.3 Vaccines Market Value Analysis
6.5.4 Recent Development
6.6 Mitsubishi Tanabe Pharma
6.6.1 Business Overview
6.6.2 Vaccines Portfolio
6.6.3 Vaccines Market Value Analysis
6.6.4 Promising Vaccines in the Clinical Development
6.6.5 Recent Development
6.7 Emergent BioSolutions
6.7.1 Business Overview
6.7.2 Vaccines Portfolio
6.7.3 Vaccines Market Value Analysis
6.7.4 Promising Vaccines in the Clinical Development
6.7.5 Recent Development
6.8 Astlellas Pharma Inc
6.8.1 Business Overview
6.8.2 Vaccines Portfolio
6.8.3 Vaccines Market Value Analysis
6.8.4 Recent Development
6.9 Valneva
6.9.1 Business Overview
6.9.2 Vaccines Portfolio
6.9.3 Vaccines Market Value Analysis
6.9.4 Promising Vaccines in the Clinical Development
6.9.5 Recent Development
6.10 Seqirus (CSL Limited) 
6.10.1 Business Overview
6.10.2 Vaccines Portfolio
6.10.3 Vaccines Market Value Analysis
6.10.4 Promising Vaccines in the Clinical Development
6.10.5 Recent Development
6.11 Bavarian Nordic
6.11.1 Business Overview
6.11.2 Vaccines Portfolio
6.11.3 Vaccines Market Value Analysis
6.11.4 Promising Vaccines in the Clinical Development
6.11.5 Recent Development
6.12 Sinovac
6.12.1 Business Overview
6.12.2 Vaccines Portfolio
6.12.3 Vaccines Market Value Analysis
6.12.4 Promising Vaccines in the Clinical Development
6.12.5 Recent Development
6.13 Panacea Biotec
6.13.1 Business Overview
6.13.2 Vaccines Portfolio
6.13.3 Vaccines Market Value Analysis
6.13.4 Promising Vaccines in the Clinical Development
6.13.5 Recent Development
6.14 Dynavax Technologies Corporation
6.14.1 Business Overview
6.14.2 Vaccines Portfolio
6.14.3 Vaccines Market Value Analysis
6.14.4 Promising Vaccines in the Clinical Development
6.14.5 Recent Development
6.15 Bharat Biotech
6.15.1 Business Overview
6.15.2 Vaccines Portfolio
6.15.3 Promising Vaccines in the Clinical Development
6.15.4 Recent Development
6.16 Serum Institute of India
6.16.1 Business Overview
6.16.2 Vaccines Portfolio
6.16.3 Promising Vaccines in Clinical Development
6.16.4 Recent Development
6.17 Biological E. Limited
6.17.1 Business Overview
6.17.2 Vaccines Portfolio
6.17.3 Promising Vaccines in the Clinical Development
6.17.4 Recent Development
6.18 Grifols
6.18.1 Business Overview
6.18.2 Vaccines Portfolio
6.18.3 Recent Development
6.19 Hualan Biological Engineering Inc
6.19.1 Business Overview
6.19.2 Influenza Vaccines Portfolio
6.19.3 Recent Development
6.20 Gamma Vaccines Pty Ltd
6.20.1 Business Overview
6.20.2 Influenza Vaccines Portfolio
6.20.3 Recent Development

List of Tables:

Table 5–1: Merger & Acquisitions in the Vaccine Market
Table 5–2: Collaboration Deals in the Vaccine Market
Table 5–3: Licensing Agreement in the Vaccine Market
Table 5–4: Exclusive Agreement in the Vaccine Market
Table 5–5: Distribution Agreement in the Vaccine Market
Table 5–6: Partnership Deals in the Vaccine Market
Table 6–1: Sanofi Promising Vaccines in the Clinical Development
Table 6–2: GSK Promising Vaccines in the Clinical Development
Table 6–3: Merck Promising Vaccines in the Clinical Development
Table 6–4: Pfizer Promising Vaccines in the Clinical Development
Table 6–5: Mitsubishi Tanabe Pharma Promising Vaccines in the Clinical Development
Table 6–6: Emergent Biosolutions Promising Vaccines in the Clinical Development
Table 6–7: Valneva Promising Vaccines in the Clinical Development
Table 6–8: Seqirus Promising Vaccines in the Clinical Development
Table 6–9: Bavarian Nordic Promising Vaccines in the Clinical Development
Table 6–10: Sinovac Promising Vaccines in the Clinical Development
Table 6–11: Panacea Biotec Promising Vaccines in the Clinical Development
Table 6–12: Dynavax Technologies Corporation Promising Vaccines in the Clinical Development
Table 6–13: Bharat Biotech Promising Vaccines in the Clinical Development

List of Figures:

Figure 2–1: Global Top 20 Vaccine Companies Sales Value (Million US$),2015 – 2019
Figure 3–1: Market Share Analysis of the Top 20 Vaccine Companies (Percent), 2019
Figure 6–1: Sanofi Pasteur Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–2: GSK Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–3: Merck Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–4: Pfizer Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–5: AstraZeneca Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 6–6: Mitsubishi Tanabe Pharma Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 6–7: Emergent Biosolutions Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–8: Astlellas Pharma Inc Vaccines Market Value Analysis (Million US$),2015 – 2018
Figure 6–9: Valneva Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–10: Seqirus Vaccines Market Value Analysis (Million US$),2015 - 2019
Figure 6–11: Bavarian Nordic Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–12: Sinovac Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–13: Panacea Biotec Vaccines Market Value Analysis (Million US$),2015 – 2019
Figure 6–14: Dynavax Vaccines Market Value Analysis (Million US$),2018 – 2019

Why http://www.marketreportsonline.com/
Published By :DPI Research
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy